Skip to main content

Branded

  • FDA approves Eisai’s Lenvima for advanced renal cell carcinoma

    SILVER SPRING, Md. — The Food and Drug Administration on Friday approved a new indication for Eisai’s Lenvima (lenvatinib). The multiple receptor tyrosine kinase inhibitor has been approved to treat advanced renal cell carcinoma (RCC) in combination with everolimus in patients previously treated with an anti-angiogenic therapy. 
     
  • MD Labs' Rxight advances President's Precision Medicine Initiative

    WASHINGTON – In an effort to expand upon President Barack Obama’s Precision Medicine Initiative and explore innovative ways to individualize patient care, representatives from MD Labs recently met with senior leadership at the White House Office of Science and Technology Policy.
     
  • Cigna inks outcome-based payment contracts with makers of Praluent, Repatha

    BLOOMFIELD, Conn. — Cigna on Tuesday announced that it had signed value-based contracts with the makers of PCSK9 inhibitors Praluent and Repatha. The contracts — with Sanofi and Regeneron for Praluent and Amgen for Repatha — will tie patient outcomes to the price Cigna pays for the medications, which have been estimated to cost as much as $14,000 per patient per year. 
     
  • Boston researchers crack real-time tracking of flu season

    BOSTON - Big data is playing a role in better tracking flu outbreaks in real time, a team of researchers found, just not necessarily through Google searches. A team led by researchers at Boston Children's Hospital found that cloud-based data from electronic health records can be used to pick up cases in real time, at least one week ahead of CDC reporting.
     
  • DEA collects record amount of meds at National Rx Take-Back-Day

    WASHINGTON — Americans turned in a record number of unused prescription drugs last weekend, according to the Drug Enforcement Agency. The DEA on Monday said  the most recent National Prescription Drug Take-Back Day brought in the most unused prescription medications of any of its previous 10 events held since the initiative launched in 2010. 
     
  • Study: Moms who get flu shot while pregnant provide significant protection to newborn

    SALT LAKE CITY - Babies whose moms get flu vaccinations while pregnant have a significantly reduced risk of acquiring influenza during their first six months of life, a new study shows, leading the authors to declare that the need for getting more pregnant women immunized is a public health priority.
     
  • CDC: At least 30% of antibiotic scripts unnecessary

    ATLANTA — The Centers for Disease Control and Prevention, according to new data published Tuesday in the Journal of the American Medical Association that at least 1-in-3 antibiotic prescriptions are unnecessary. The study looks at antibiotic use in doctors’ offices and emergency rooms nationwide, finding that some 47 million excess antibiotic prescriptions are written for viral respiratory conditions. 
     
  • Mylan names new CFO

    PITTSBURGH — Mylan on Tuesday announced the appointment of Kenneth Parks as its new CFO, effective June 6. Parks, who has more than 30 years of corporate finance experience, will join Mylan from Wesco International, a provider of electrical, industrial and communications products, where he is VP and CFO. 
     
X
This ad will auto-close in 10 seconds